1-(p-Tolyl)-2,5,8,11,14-pentaoxahexadecan-16-yl 4-methylbenzenesulfonate, 98%, 1g

2-Isopropyl-6-methoxypyridine, 95%, 5g

3-(CYCLOPENTYLOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-METHOXYBENZAMIDE, 95%, 5mg

TERT-BUTYL 3,3-DIMETHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,6-TETRAHYDROPYRIDINE-1-CARBOXYLATE, 95.0%, 5g

4-(3-Nitrophenyl)-1,2,3,6-tetrahydropyridine hydrochloride, 97%, 250mg

2-Amino-4-methyl-3-nitropyridine, 97.0%, 500g

6-chloro-2H-pyrazolo[3,4-d]pyrimidin-4-amine, 97%, 100mg

Recipiente di reazione a flangia piatta cilindrico, graduato (2) Fondo piatto, DN 60, 65 mm, Altezza, 75 mm, 1 Pezzo

1-Bromo-3-fluoro-5-nitrobenzene, 95.0%, 25g

2-Fluoro-5-(hydroxymethyl)benzonitrile, 95.0%, 10g

1-Methyl-1H-1,2,4-triazol-3-amine, 95.0%, 1g

Benzyl (S)-(-)-Lactate, 98.0%, 100g

1,2,4,5-Tetra(1H-imidazol-1-yl)benzene, 98%, 250mg